Iron deficiency anemia and reactive thrombocytosis in a woman with heavy menstrual bleeding: A case report

This is a preview and has not been published.

Iron deficiency anemia and reactive thrombocytosis in a woman with heavy menstrual bleeding: A case report

Authors

  • Khaldun Jacoub Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa 13133, Jordan https://orcid.org/0000-0002-5949-7950
  • Eman Emran Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa 13133, Jordan https://orcid.org/0009-0005-7269-8641
  • Ali Abdelfattah Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa 13133, Jordan. European Cancer Stem Cell Research Institute, Cardiff University, School of Biosciences, Cardiff, UK. https://orcid.org/0000-0003-0294-0568

Keywords:

Essential Thrombocythemia, Iron Deficiency Anemia , Thrombocytosis

Abstract

Thrombocytosis is frequently encountered in clinical practice and requires a rigorous diagnostic approach to accurately determine its underlying cause. It could be primary, such as essential thrombocythemia (ET), or secondary to chronic inflammation, hemorrhage, or iron deficiency anemia (IDA). Herein, a 32-year-old woman was initially diagnosed with ET and treated with cytoreduction and an antiplatelet agent. Despite this, her erythrocyte counts increased, accompanied by microcytic hypochromic anemia. Laboratory tests and detailed clinical reassessment ultimately identified IDA secondary to polymenorrhagia as the cause of her anemia. Iron supplements, along with the absence of an iron deficiency trigger, improved her hematologic parameters. She was subsequently reclassified as a case of IDA with reactive thrombocytosis. Misdiagnosis led to improper management and treatment of IDA. This case highlights to clinicians that thrombocytosis is mainly secondary to an underlying trigger, and the definitive diagnosis of the rare ET requires fulfilment of the well-established criteria.

References

1. Almanaseer A, Chin-Yee B, Ho J, Lazo-Langner A, et al. An approach to the investigation of thrombocytosis: differentiating between essential thrombocythemia and secondary thrombocytosis. Advances in Hematology. 2024;2024(1):3056216. doi: 10.1155/2024/3056216.

2. Cappellini M, Musallam KM, Taher AT. Iron deficiency anaemia revisited. Journal of internal medicine. 2020;287(2):153-70. doi: 10.1111/joim.13004.

3. Li N, Zhao G, Wu W, Zhang M, et al. The efficacy and safety of vitamin C for iron supplementation in adult patients with iron deficiency anemia: a randomized clinical trial. JAMA network open. 2020;3(11):e2023644-e. doi: 10.1001/jamanetworkopen.

4. Iolascon A, Andolfo I, Russo R, et al. Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemia. Hemasphere. 2024;8(7):e108. doi: 10.1002/hem3.108.

5. Song AB, Kuter DJ, Al-Samkari H. Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemia. American Journal of Hematology. 2020;95(10):1180-6. doi: 10.1002/ajh.25925.

6. Li X, Li N, Zhao G, Wang X. Effect of iron supplementation on platelet count in adult patients with iron deficiency anemia. Platelets. 2022;33(8):1214-9. doi: 10.1080/09537104.2022.2091772.

7. Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. leukemia. 2022;36(7):1703-19. doi: 10.1038/s41375-022-01613-1.

8. Tefferi A, Vannucchi AM, Barbui T. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management. American journal of hematology. 2024;99:697-718. doi: 10.1002/ajh.27216.

9. Loscocco GG, Gesullo F, Capecchi G, et al. One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood Cancer Journal. 2024;14(1):10. doi: 10.1038/s41408-023-00968-7.

10. Thiele J, Kvasnicka HM, Gianelli U, et al. Evolution of WHO diagnostic criteria in “Classical Myeloproliferative Neoplasms” compared with the International Consensus Classification. Blood cancer journal. 2025;15(1):31. doi: 10.1038/s41408-025-01235-7.

11. Bose S, Maimoon S. Is Mentzer index a reliable diagnostic screening tool for beta thalassemia trait. IOSR J Dent Med Sci. 2018;17(7):7-11. doi: 10.9790/0853-1707060711.

12. Voigt W, Jordan K, Sippel C, Amoury M, Schmoll H-J, Wolf HH. Severe thrombocytosis and anemia associated with celiac disease in a young female patient: a case report. Journal of Medical Case Reports. 2008;2(1):96. doi: 10.1186/1752-1947-2-96.

13. Xavier-Ferrucio J, Scanlon V, Li X, et al. Low iron promotes megakaryocytic commitment of megakaryocytic-erythroid progenitors in humans and mice. Blood. 2019;134(18):1547-57. doi: 10.1182/blood.2019002039.

How to Cite

1.
Jacoub K, Emran E, Abdelfattah A. Iron deficiency anemia and reactive thrombocytosis in a woman with heavy menstrual bleeding: A case report. Acta Biomed. 97(3):19161. doi:10.23750/abm.2026.19161

Issue

Section

CASE REPORTS

How to Cite

1.
Jacoub K, Emran E, Abdelfattah A. Iron deficiency anemia and reactive thrombocytosis in a woman with heavy menstrual bleeding: A case report. Acta Biomed. 97(3):19161. doi:10.23750/abm.2026.19161